Conagen's innovative high-throughput screening process identifies phenolic molecules made through precision fermentation as natural preservative replacements for traditional sorbates and benzoates. These advanced formulations promise enhanced antimicrobial efficacy and natural labeling in food applications.
Conagen, Inc. is pioneering the development of natural preservatives through precision fermentation and bioconversion. By leveraging phenolic molecules, the company aims to replace traditional preservatives like sorbate and benzoate, meeting consumer demand for natural ingredients without compromising on efficacy. This innovative approach not only maintains acceptable organoleptic properties but also enables products to carry a "natural preservative" label, appealing to health-conscious consumers.
Conagen's high-throughput screening (HTS) assay efficiently evaluates combinations of antimicrobial and antioxidant compounds. The process involves challenging a cocktail of yeasts, including Saccharomyces cerevisiae, Candida rugopelliculosa, and Zygosaccharomyces bailii, with these compounds. Synergistic combinations showing high efficacy are further tested against molds and bacteria and undergo sensory studies. The HTS system allows for testing both single and multi-component preservative formulations, initially at solubility-limited concentrations, to identify optimal natural preservative solutions.
Conagen's technology is currently at TRL 5, indicating that it has been validated in relevant environments. The company's lead natural preservatives have progressed to scale-up and regulatory filing stages, demonstrating readiness for commercial advancement.
Conagen is a biotech company specializing in synthetic biology and fermentation to produce natural ingredients for food, flavor, fragrance, pharma, and other markets.